This post was originally published on this site
© Reuters. NextGen Healthcare (NXGN) taken private by Thoma Bravo, key facts about the deal
NextGen Healthcare Inc (NASDAQ:) has entered into a definitive agreement to be acquired by Thoma Bravo. Here are key facts about the transaction:
- Shareholders of NextGen Healthcare will receive $23.95 per share in cash as part of the agreement, representing a 46.4% premium to the company’s unaffected closing stock price on August 22 and a 39.2% premium to the 30-day volume-weighted average price ending on September 1.
- The agreement was approved unanimously by the NextGen Healthcare Board of Directors and follows interest from various parties, reflecting a deliberate process to maximize shareholder value and position the company for growth and success.
- The transaction is expected to close in the fourth calendar quarter of 2023, subject to customary closing conditions, including approval by NextGen Healthcare shareholders and required regulatory approvals.
-
The acquisition will provide immediate cash value to NextGen Healthcare shareholders and offer the company increased capital, expertise, and strategic flexibility to strengthen its position in providing healthcare technology solutions.
-
Upon completion of the transaction, NextGen Healthcare will become a privately held company.
